161 related articles for article (PubMed ID: 38131308)
21. Practical genetics of colorectal cancer.
Lynch HT; Shaw TG
Chin Clin Oncol; 2013 Jun; 2(2):12. PubMed ID: 25841492
[TBL] [Abstract][Full Text] [Related]
22. Hereditary Colorectal Polyposis and Cancer Syndromes: A Primer on Diagnosis and Management.
Kanth P; Grimmett J; Champine M; Burt R; Samadder NJ
Am J Gastroenterol; 2017 Oct; 112(10):1509-1525. PubMed ID: 28786406
[TBL] [Abstract][Full Text] [Related]
23. Implementing genomic screening in diverse populations.
Abul-Husn NS; Soper ER; Braganza GT; Rodriguez JE; Zeid N; Cullina S; Bobo D; Moscati A; Merkelson A; Loos RJF; Cho JH; Belbin GM; Suckiel SA; Kenny EE
Genome Med; 2021 Feb; 13(1):17. PubMed ID: 33546753
[TBL] [Abstract][Full Text] [Related]
24. Co-Occurrence of Familial Non-Medullary Thyroid Cancer (FNMTC) and Hereditary Non-Polyposis Colorectal Cancer (HNPCC) Associated Tumors-A Cohort Study.
Aswath K; Welch J; Gubbi S; Veeraraghavan P; Avadhanula S; Gara SK; Dikoglu E; Merino M; Raffeld M; Xi L; Kebebew E; Klubo-Gwiezdzinska J
Front Endocrinol (Lausanne); 2021; 12():653401. PubMed ID: 34326811
[TBL] [Abstract][Full Text] [Related]
25. Genetic testing for cancer predisposition.
Eng C; Hampel H; de la Chapelle A
Annu Rev Med; 2001; 52():371-400. PubMed ID: 11160785
[TBL] [Abstract][Full Text] [Related]
26. Population genetic screening efficiently identifies carriers of autosomal dominant diseases.
Grzymski JJ; Elhanan G; Morales Rosado JA; Smith E; Schlauch KA; Read R; Rowan C; Slotnick N; Dabe S; Metcalf WJ; Lipp B; Reed H; Sharma L; Levin E; Kao J; Rashkin M; Bowes J; Dunaway K; Slonim A; Washington N; Ferber M; Bolze A; Lu JT
Nat Med; 2020 Aug; 26(8):1235-1239. PubMed ID: 32719484
[TBL] [Abstract][Full Text] [Related]
27. "I have always lived with the disease in the family": family adaptation to hereditary cancer-risk.
Silva E; Gomes P; Matos PM; Silva ER; Silva J; Brandão C; Castro F; Neves MC; Sales CMD
BMC Prim Care; 2022 Apr; 23(1):93. PubMed ID: 35461227
[TBL] [Abstract][Full Text] [Related]
28. Cost-effectiveness of Population-Wide Genomic Screening for Hereditary Breast and Ovarian Cancer in the United States.
Guzauskas GF; Garbett S; Zhou Z; Spencer SJ; Smith HS; Hao J; Hassen D; Snyder SR; Graves JA; Peterson JF; Williams MS; Veenstra DL
JAMA Netw Open; 2020 Oct; 3(10):e2022874. PubMed ID: 33119106
[TBL] [Abstract][Full Text] [Related]
29. Rapid mutation scanning of genes associated with familial cancer syndromes using denaturing high-performance liquid chromatography.
Marsh DJ; Theodosopoulos G; Howell V; Richardson AL; Benn DE; Proos AL; Eng C; Robinson BG
Neoplasia; 2001; 3(3):236-44. PubMed ID: 11494117
[TBL] [Abstract][Full Text] [Related]
30. Uptake of prenatal diagnostic testing for retinoblastoma compared to other hereditary cancer syndromes in the Netherlands.
Dommering CJ; Henneman L; van der Hout AH; Jonker MA; Tops CM; van den Ouweland AM; van der Luijt RB; Mensenkamp AR; Hogervorst FB; Redeker EJ; de Die-Smulders CE; Moll AC; Meijers-Heijboer H
Fam Cancer; 2017 Apr; 16(2):271-277. PubMed ID: 27826806
[TBL] [Abstract][Full Text] [Related]
31. Inherited cancer syndromes and the thyroid: an update.
Metzger R; Milas M
Curr Opin Oncol; 2014 Jan; 26(1):51-61. PubMed ID: 24300902
[TBL] [Abstract][Full Text] [Related]
32. Familial adenomatous polyposis.
Half E; Bercovich D; Rozen P
Orphanet J Rare Dis; 2009 Oct; 4():22. PubMed ID: 19822006
[TBL] [Abstract][Full Text] [Related]
33. Familial hypercholesterolemia is related to cardiovascular disease, heart failure and atrial fibrillation. Results from a population-based study.
Tada H; Kaneko H; Suzuki Y; Okada A; Takeda N; Fujiu K; Morita H; Ako J; Node K; Takeji Y; Takamura M; Yasunaga H; Komuro I
Eur J Clin Invest; 2024 Feb; 54(2):e14119. PubMed ID: 37916502
[TBL] [Abstract][Full Text] [Related]
34. Colonic adenomatous polyposis syndromes: clinical management.
Ellis CN
Clin Colon Rectal Surg; 2008 Nov; 21(4):256-62. PubMed ID: 20011436
[TBL] [Abstract][Full Text] [Related]
35. Reduced life expectancy seen in hereditary diseases which predispose to early-onset tumors.
Evans DG; Ingham SL
Appl Clin Genet; 2013; 6():53-61. PubMed ID: 23935382
[TBL] [Abstract][Full Text] [Related]
36. PTEN germline mutations in patients initially tested for other hereditary cancer syndromes: would use of risk assessment tools reduce genetic testing?
Mester JL; Moore RA; Eng C
Oncologist; 2013; 18(10):1083-90. PubMed ID: 24037976
[TBL] [Abstract][Full Text] [Related]
37. Cancer Predisposition Cascade Screening for Hereditary Breast/Ovarian Cancer and Lynch Syndromes in Switzerland: Study Protocol.
Katapodi MC; Viassolo V; Caiata-Zufferey M; Nikolaidis C; Bührer-Landolt R; Buerki N; Graffeo R; Horváth HC; Kurzeder C; Rabaglio M; Scharfe M; Urech C; Erlanger TE; Probst-Hensch N; Heinimann K; Heinzelmann-Schwarz V; Pagani O; Chappuis PO
JMIR Res Protoc; 2017 Sep; 6(9):e184. PubMed ID: 28931501
[TBL] [Abstract][Full Text] [Related]
38. Plasma normetanephrine and metanephrine for detecting pheochromocytoma in von Hippel-Lindau disease and multiple endocrine neoplasia type 2.
Eisenhofer G; Lenders JW; Linehan WM; Walther MM; Goldstein DS; Keiser HR
N Engl J Med; 1999 Jun; 340(24):1872-9. PubMed ID: 10369850
[TBL] [Abstract][Full Text] [Related]
39. Hereditary colorectal cancer syndromes: familial adenomatous polyposis and lynch syndrome.
Al-Sukhni W; Aronson M; Gallinger S
Surg Clin North Am; 2008 Aug; 88(4):819-44, vii. PubMed ID: 18672142
[TBL] [Abstract][Full Text] [Related]
40. Controversies in the surgery of patients with familial adenomatous polyposis and Lynch syndrome.
Church JM
Fam Cancer; 2016 Jul; 15(3):447-51. PubMed ID: 26869170
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
